谷歌浏览器插件
订阅小程序
在清言上使用

Real-World Evidence for Favourable Quality-of-Life Outcomes in Hungarian Patients with Relapsing-Remitting Multiple Sclerosis Treated for Two Years with Oral Teriflunomide: Results of the Teri-REAL Study

Pharmaceuticals(2022)

引用 4|浏览20
暂无评分
关键词
teriflunomide,multiple sclerosis,quality-of-life,cognition,fatigue,efficacy,real-world study,disability
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要